Multiplex Patient-Based Drug Response Assay in Pancreatic Ductal Adenocarcinoma

Pancreatic ductal adenocarcinoma (PDA) is an extremely lethal malignancy arising from the pancreas. The treatment of PDA is complicated by ineffective treatments and a lack of biomarkers predictive of treatment success. We have designed a patient-derived organoid (PDO) based high-throughput drug scr...

Descripción completa

Detalles Bibliográficos
Autores principales: Armstrong, Andrew, Haque, Muhammad R., Mirbagheri, Sina, Barlass, Usman, Gilbert, Douglas Z., Amin, Jaimin, Singh, Ajaypal, Naqib, Ankur, Bishehsari, Faraz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8301364/
https://www.ncbi.nlm.nih.gov/pubmed/34201419
http://dx.doi.org/10.3390/biomedicines9070705

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8301364/
https://www.ncbi.nlm.nih.gov/pubmed/34201419
http://dx.doi.org/10.3390/biomedicines9070705

Ejemplares similares